Table 4.
Apnea-hypopnea index (events per hour) |
|||||
---|---|---|---|---|---|
<5.0 | 5.0 to 14.9 | 15.0 to 29.9 | ≥ 30.0 | P value† | |
Men | |||||
Number of subjects | 829 | 644 | 282 | 172 | |
Number of heart failure events | 44 | 46 | 25 | 26 | |
Covariates in model | |||||
Age, race, BMI, smoking | 1.00 (referent) | 0.96 (0.63, 1.46) | 1.17 (0.71, 1.94) | 1.61 (0.95, 2.71) | 0.03 |
+ total and HDL cholesterol, lipid- lowering meds, diabetes mellitus | 1.00 (referent) | 0.90 (0.59, 1.38) | 1.08 (0.65, 1.80) | 1.59 (0.94, 2.69) | 0.02 |
+ SBP, DBP, use of anti- hypertensive medications | 1.00 (referent) | 0.88 (0.57, 1.35) | 1.13 (0.68, 1.89) | 1.58 (0.93, 2.66) | 0.02 |
Women | |||||
Number of subjects | 1605 | 610 | 196 | 84 | |
Number of heart failure events | 86 | 54 | 19 | 8 | |
Covariates in model | |||||
Age, race, BMI, smoking | 1.00 (referent) | 1.12 (0.79, 1.59) | 1.10 (0.66, 1.83) | 1.05 (0.50, 2.23) | 0.72 |
+ total and HDL cholesterol, lipid- lowering meds, diabetes mellitus | 1.00 (referent) | 1.15 (0.81, 1.63) | 1.06 (0.64, 1.77) | 1.19 (0.56, 2.53) | 0.90 |
+ SBP, DBP, use of anti- hypertensive medications | 1.00 (referent) | 1.13 (0.80, 1.61) | 1.01 (0.60, 1.69) | 1.19 (0.56, 2.52) | 0.83 |
Results are adjusted hazard ratio (95% confidence interval)
P value for the overall effect of AHI modeled as a continuous variable